Search alternatives:
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
non decrease » point decrease (Expand Search), note decreased (Expand Search), mean decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
non decrease » point decrease (Expand Search), note decreased (Expand Search), mean decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1061
Table1_Population pharmacokinetic study of pemetrexed in chinese primary advanced non-small cell lung carcinoma patients.xlsx
Published 2022“…Creatinine clearance (CrCl) was identified as a covariate to CL, and ERCC1 (rs3212986) and CYP3A5 (rs776746) gene polymorphisms as covariates to Q. …”
-
1062
Table1_Population pharmacokinetic study of pemetrexed in chinese primary advanced non-small cell lung carcinoma patients.xlsx
Published 2022“…Creatinine clearance (CrCl) was identified as a covariate to CL, and ERCC1 (rs3212986) and CYP3A5 (rs776746) gene polymorphisms as covariates to Q. …”
-
1063
Table2_Population pharmacokinetic study of pemetrexed in chinese primary advanced non-small cell lung carcinoma patients.docx
Published 2022“…Creatinine clearance (CrCl) was identified as a covariate to CL, and ERCC1 (rs3212986) and CYP3A5 (rs776746) gene polymorphisms as covariates to Q. …”
-
1064
-
1065
Decreased surfactant lipids correlate with lung function in chronic obstructive pulmonary disease (COPD)
Published 2020“…Bronchoalveolar lavage (BAL) fluid was obtained from 12 former smokers with COPD and 5 non-smoking, non-asthmatic healthy control volunteers. …”
-
1066
-
1067
-
1068
-
1069
-
1070
-
1071
-
1072
WT1 siRNA decreases proliferation, pAKT, and Bcl2 expression.
Published 2024“…Corresponding densitometry analysis is noted as protein fold expression compared to GAPDH for WT1, p<0.001(***), vFLIP(ns), LANA p<0.05(*), pAKT p<0.05(*), and BCL2 p <0.05(*) using two-sided, unpaired student t-tests. …”
-
1073
Global Land Use Change Impacts on Soil Nitrogen Availability and Environmental Losses
Published 2025“…However, how global land use changes impact soil N supply and potential N loss remains elusive. By compiling a global data set of 1,782 paired observations from 185 publications, we show that land use conversion from natural to managed ecosystems significantly reduced NNM by 7.5% (−11.5, −2.8%) and increased NN by 150% (86, 194%), indicating decreasing N availability while increasing potential N loss through denitrification and nitrate leaching. …”
-
1074
-
1075
-
1076
-
1077
-
1078
2D-PAGE images and Venn diagram showing differential protein expression (>2-fold) between CON and HFX (A-D).
Published 2022“…Green circles indicate group paired spots, and orange circles indicate group non-paired spots. The images of the 2D-PAGE show an increase of 43 spots (B) and a decrease of 17 spots (C) among the 268 paired spots in HFD compared to CON. …”
-
1079
2D-PAGE images and Venn diagram showing differential protein expression (>2-fold) between HFD and HFX (A-D).
Published 2022“…Green circles indicate group paired spots, and orange circles indicate group non-paired spots. The images of the 2D-PAGE show an increase of 35 spots (B) and a decrease of 8 spots (C) among the 264 paired spots in HFD compared to CON. …”
-
1080
Time course of best-corrected visual acuity (BCVA) in recurrence and non-recurrence groups.
Published 2025“…In the non-recurrence group, CRT improved from 482.5 ± 112.8 to 294.7 ± 65.3, 302.0 ± 68.0, 284.7 ± 55.4, 285.3 ± 70.2, 265.2 ± 65.0, and 266.1 ± 78.2 μm at 1, 3, 6, 12, 24, and 36 months, respectively (Kruskal-Wallis test, p < 0.001; <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0332941#pone.0332941.g006" target="_blank">Fig 6</a>).…”